跳至主要内容
临床试验/IRCT20130812014333N184
IRCT20130812014333N184招募中未知

Evaluation of the therapeutic efficiency of the placenta mesenchymal stem cell-derived exosomes on the improvement of interstitial lung disease symptoms in systemic sclerosis patients, a single-arm trial.

Kermanshah University of Medical Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Informed consent
  • American College of Rheumatology (ACR) and EULAR2013 diagnostic criteria for systemic sclerosis
  • Intestinal lung disease confirmed by chest CT scan and lung function tests

排除标准

  • Suffering from other autoimmune diseases
  • Uncontrolled high blood pressure, diabetes, and other endocrine disorders
  • Cardiovascular failure
  • Chronic renal failure
  • Hepatic impairment
  • Existence of life-threatening conflicts including severe platelet hemolysis below 40,000
  • Pregnancy and lactation

研究者

相似试验

Evaluation of the therapeutic efficiency of the... | 临床试验